Literature DB >> 27037223

Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

F V Brozovich1, C J Nicholson1, C V Degen1, Yuan Z Gao1, M Aggarwal1, K G Morgan2.   

Abstract

The smooth muscle cell directly drives the contraction of the vascular wall and hence regulates the size of the blood vessel lumen. We review here the current understanding of the molecular mechanisms by which agonists, therapeutics, and diseases regulate contractility of the vascular smooth muscle cell and we place this within the context of whole body function. We also discuss the implications for personalized medicine and highlight specific potential target molecules that may provide opportunities for the future development of new therapeutics to regulate vascular function.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Mesh:

Substances:

Year:  2016        PMID: 27037223      PMCID: PMC4819215          DOI: 10.1124/pr.115.010652

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  687 in total

1.  p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA.

Authors:  Yasuhiko Koga; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2004-11-14       Impact factor: 5.157

Review 2.  Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys?

Authors:  Lisa M Nilsson; Jenny Nilsson-Ohman; Anna V Zetterqvist; Maria F Gomez
Journal:  Curr Opin Lipidol       Date:  2008-10       Impact factor: 4.776

3.  MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K⁺ channel in arterial smooth muscle cells.

Authors:  Shan-Shan Li; Ya-Juan Ran; Dan-Dan Zhang; Shu-Zhen Li; Daling Zhu
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

4.  Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity.

Authors:  K Ichikawa; M Ito; D J Hartshorne
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

5.  Ablation of smooth muscle caldesmon affects the relaxation kinetics of arterial muscle.

Authors:  Hongqiu Guo; Renjian Huang; Shingo Semba; Jolanta Kordowska; Yang Hoon Huh; Yana Khalina-Stackpole; Katsuhide Mabuchi; Toshio Kitazawa; Chih-Lueh Albert Wang
Journal:  Pflugers Arch       Date:  2012-11-14       Impact factor: 3.657

6.  Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.

Authors:  A Sotiropoulos; D Gineitis; J Copeland; R Treisman
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

7.  Agonist-specific myosin phosphorylation and intracellular calcium during isometric contractions of arterial smooth muscle.

Authors:  M J Jiang; K G Morgan
Journal:  Pflugers Arch       Date:  1989-04       Impact factor: 3.657

8.  Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure.

Authors:  K Mary Tang; Guang-rong Wang; Ping Lu; Richard H Karas; Mark Aronovitz; Scott P Heximer; Kevin M Kaltenbronn; Kendall J Blumer; David P Siderovski; Yan Zhu; Michael E Mendelsohn; Mary Tang; Guang Wang
Journal:  Nat Med       Date:  2003-11-09       Impact factor: 53.440

9.  Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery.

Authors:  G Gamble; J Zorn; G Sanders; S MacMahon; N Sharpe
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

10.  Identification of the sequence of the regulatory light chain required for the phosphorylation-dependent regulation of actomyosin.

Authors:  M Ikebe; J Morita
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

View more
  119 in total

1.  Fundamental Roles of Axial Stretch in Isometric and Isobaric Evaluations of Vascular Contractility.

Authors:  Alexander W Caulk; Jay D Humphrey; Sae-Il Murtada
Journal:  J Biomech Eng       Date:  2019-03-01       Impact factor: 2.097

2.  LIMK (LIM Kinase) Inhibition Prevents Vasoconstriction- and Hypertension-Induced Arterial Stiffening and Remodeling.

Authors:  Mariana Morales-Quinones; Francisco I Ramirez-Perez; Christopher A Foote; Thaysa Ghiarone; Larissa Ferreira-Santos; Maria Bloksgaard; Nicole Spencer; Eric T Kimchi; Camila Manrique-Acevedo; Jaume Padilla; Luis A Martinez-Lemus
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

3.  Tethering transforming growth factor β1 to soft hydrogels guides vascular smooth muscle commitment from human mesenchymal stem cells.

Authors:  Yonghui Ding; Richard Johnson; Sadhana Sharma; Xiaoyun Ding; Stephanie J Bryant; Wei Tan
Journal:  Acta Biomater       Date:  2020-01-23       Impact factor: 8.947

4.  Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries.

Authors:  Fan Fan; Mallikarjuna R Pabbidi; Ying Ge; Longyang Li; Shaoxun Wang; Paige N Mims; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-07

5.  Ca2+/calmodulin/MLCK pathway initiates, and RhoA/ROCK maintains, the internal anal sphincter smooth muscle tone.

Authors:  Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-12-08       Impact factor: 4.052

6.  Functional insights into the Magnaporthe oryzae class II myosin.

Authors:  Thabiso E Motaung; Toi J Tsilo
Journal:  Virulence       Date:  2017-06-01       Impact factor: 5.882

Review 7.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

8.  Vasoconstrictor stimulus determines the functional contribution of myoendothelial feedback to mesenteric arterial tone.

Authors:  R Wei; S E Lunn; R Tam; S L Gust; B Classen; P M Kerr; F Plane
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

9.  Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Authors:  Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum
Journal:  Am J Nephrol       Date:  2018-08-02       Impact factor: 3.754

10.  Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry.

Authors:  Fernando P Filgueira; Núbia S Lobato; Denise L Nascimento; Graziela S Ceravolo; Fernanda R C Giachini; Victor V Lima; Ana Paula Dantas; Zuleica B Fortes; R Clinton Webb; Rita C Tostes; Maria Helena C Carvalho
Journal:  Steroids       Date:  2018-11-17       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.